Hainan
605199.SSHainan Huluwa Pharmaceutical Group Co., Ltd. Price (605199.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
394,436,231
(1.4177)%Income Statement Summary
| Revenue | |
| Cost of Revenue | |
| Gross Profit | |
| Operating Expenses | |
| Operating Income | |
| Other Expenses | |
| Net Income |
Income Statement
Hainan Huluwa Pharmaceutical Group Co., Ltd.Currency: CNY
| YEAR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||
| Revenue |
487,353,546.00
+0% |
655,005,486.00
+34% |
983,772,603.00
+50% |
1,305,918,058.00
+33% |
1,161,705,769.00
-11% |
1,353,793,179.00
+17% |
1,515,046,453.00
+12% |
1,905,182,163.00
+26% |
|||||||||||
| Cost of Revenue | |||||||||||||||||||
| Cost of Revenue | 291,207,769.00 | 336,976,245.00 | 379,953,865.00 | 496,786,137.00 | 443,653,517.00 | 545,096,690.00 | 638,582,319.00 | 907,792,407.00 | |||||||||||
| Gross Profit | |||||||||||||||||||
| Gross Profit |
196,145,777.00
+0% |
318,029,241.00
+62% |
603,818,738.00
+90% |
809,131,921.00
+34% |
718,052,252.00
-11% |
808,696,489.00
+13% |
876,464,134.00
+8% |
997,389,756.00
+14% |
|||||||||||
| Gross Profit Ratio | (0.40%) | (0.49%) | (0.61%) | (0.62%) | (0.62%) | (0.60%) | (0.58%) | (0.52%) | |||||||||||
| Operating Expenses | |||||||||||||||||||
| Research and Development | 11,198,428.00 | 19,622,809.00 | 43,334,912.00 | 51,660,937.00 | 51,662,600.00 | 100,432,109.00 | 105,661,821.00 | 93,916,497.00 | |||||||||||
| General and Administrative | 36,365,461.00 | 11,999,518.00 | 14,678,434.00 | 24,448,352.00 | 25,948,491.00 | 23,236,169.00 | 15,286,028.00 | 25,800,573.00 | |||||||||||
| Selling, General & Admin... | 127,380,098.00 | 157,955,972.00 | 402,706,132.00 | 574,102,922.00 | 501,244,080.00 | 568,819,332.00 | 599,557,164.00 | 756,425,509.00 | |||||||||||
| Selling & Marketing Exp... | 91,014,636.00 | 145,956,453.00 | 388,027,698.00 | 549,654,570.00 | 475,295,589.00 | 545,583,163.00 | 584,271,135.00 | 504,376,560.00 | |||||||||||
| Depreciation and Amortiz... | 28,421,600.00 | 28,947,600.00 | 35,786,200.00 | 41,954,679.00 | 43,815,287.00 | 48,396,953.00 | 51,572,331.00 | 59,715,392.00 | |||||||||||
| Other Expenses | 5,684,193.00 | 1,218,425.00 | 1,901,649.00 | 24,985,211.00 | 11,206,882.00 | 53,883,113.00 | 47,780,755.00 | 10,110,192.00 | |||||||||||
| Total Operating Expenses | 144,194,337.00 | 269,006,536.00 | 477,698,120.00 | 650,749,071.00 | 564,113,563.00 | 723,134,556.00 | 752,999,742.00 | 868,412,469.00 | |||||||||||
| Cost and Exponses | 435,402,107.00 | 605,982,782.00 | 857,651,986.00 | 1,147,535,209.00 | 1,007,767,080.00 | 1,268,231,247.00 | 1,391,582,061.00 | 1,768,244,605.00 | |||||||||||
| Operating Income | |||||||||||||||||||
| Operating Income |
37,376,895.00
+0% |
34,161,085.00
-9% |
116,576,532.00
+241% |
141,551,010.00
+21% |
134,172,780.00
-5% |
100,303,450.00
-25% |
96,621,835.00
-4% |
136,937,558.00
+42% |
|||||||||||
| Operating Income Ratio | (0.08%) | (0.05%) | (0.12%) | (0.11%) | (0.12%) | (0.07%) | (0.06%) | (0.07%) | |||||||||||
| Other Income and Exp... | |||||||||||||||||||
| Interest Income | 867,172.00 | 922,173.00 | 402,918.00 | 225,412.00 | 880,411.00 | 3,767,956.00 | 2,008,845.00 | 1,338,921.00 | |||||||||||
| Interest Expenses | 11,379,703.00 | 14,494,889.00 | 8,909,822.00 | 13,360,098.00 | 9,102,831.00 | 13,868,401.00 | 17,996,675.00 | 18,550,330.00 | |||||||||||
| Total Other Income/Exp... | 5,684,196.00 | 1,218,425.00 | 1,901,649.00 | 690,570.00 | 216,372.00 | -18,639,521.00 | 605,104.00 | -1,443,542.00 | |||||||||||
| EBITDA | |||||||||||||||||||
| EBITDA | 82,862,392.00 | 78,890,601.00 | 163,239,985.00 | 198,506,849.00 | 189,463,143.00 | 148,174,824.00 | 167,674,830.00 | 213,411,962.00 | |||||||||||
| EBITDA ratio | (0.18%) | (0.12%) | (0.17%) | (0.16%) | (0.17%) | (0.11%) | (0.11%) | (0.11%) | |||||||||||
| Income Before Tax | |||||||||||||||||||
| Income Before Tax | 43,061,088.00 | 35,379,510.00 | 118,478,181.00 | 142,241,580.00 | 134,389,152.00 | 81,663,929.00 | 97,226,931.00 | 135,494,016.00 | |||||||||||
| Income Before Tax Ratio | (0.09%) | (0.05%) | (0.12%) | (0.11%) | (0.12%) | (0.06%) | (0.06%) | (0.07%) | |||||||||||
| Income Tax Expense | |||||||||||||||||||
| Income Tax Expense | 9,298,189.00 | 13,251,605.00 | 17,939,364.00 | 21,912,264.00 | 12,886,670.00 | 12,108,022.00 | 12,485,197.00 | 22,873,122.00 | |||||||||||
| Net Income | |||||||||||||||||||
| Net Income | 33,762,899.00
+0% |
22,127,905.00
-34% |
100,538,817.00
+354% |
120,329,315.00
+20% |
121,502,482.00
+1% |
72,137,858.00
-41% |
85,681,971.00
+19% |
106,497,782.00
+24% |
|||||||||||
| Net Income Ratio | (0.07%) | (0.03%) | (0.10%) | (0.09%) | (0.10%) | (0.05%) | (0.06%) | (0.06%) | |||||||||||
| Earning Per Share | |||||||||||||||||||
| Basic EPS | 0.56 | 0.13 | 0.31 | 0.30 | 0.30 | 0.18 | 0.21 | 0.27 | |||||||||||
| Diluted EPS | 0.56 | 0.13 | 0.31 | 0.30 | 0.30 | 0.18 | 0.21 | 0.27 | |||||||||||
| Share Outstanding | |||||||||||||||||||
| Basic Share Outstanding | 400,109,003.00 | 170,214,654.00 | 324,318,767.00 | 400,108,752.00 | 400,108,752.00 | 400,108,752.00 | 400,108,752.00 | 394,436,231.00 | |||||||||||
| Diluted Share Outstanding | 400,109,003.00 | 170,214,654.00 | 324,318,767.00 | 400,108,752.00 | 400,108,752.00 | 400,108,752.00 | 400,108,752.00 | 394,436,231.00 | |||||||||||